Prof. Alessio Lanna, Ph.D. is the Founder of Sentcell. He obtained his Ph.D. from the University College London on Medical Research Council-Ph.D. studentship (2011-2016) and then continued as a Sir Henry Wellcome Trust Post-Doctoral Fellow at the University of Oxford (2016-2019). He currently holds an Honorary Professorship at UCL in recognition of paradigm shifting research in the field of cellular ageing and T lymphocyte senescence. He was the first to identify a hitherto unknown, multi druggable pro-ageing sMAC complex and the anti-ageing mechanism of telomere vesicle transfer at the immune synapse between APCs and T lymphocytes. He keeps on refining and sculpting the discoveries in the field of immune senescence. His mission is to make Sentcell a first in class compound making firm that will reverse or delay the ageing course of life. Lately, Alessio discovered the first functional cure to HIV applying T cell rejuvenation principles.